Article
Orally available designed miniproteins inhibit enterotoxigenic <i>Bacteroides fragilis</i> pathology by blocking toxin receptor binding
2026-06-23
Abstract excerpt
Toxigenic bacterial infections in the gut are a significant contributor to the global burden of disease. Advanced tools for protein and live biotherapeutic engineering offer potentially transformative strategies for treating such diseases, while avoiding the collateral effects of traditional antibacterials. Here we used de novo protein design to identify inhibitors of the metzincin family protease Bacteroides fra...
Topics
Open a Topic to create a Post that cites this publication.
- Bacteriophages and microbial interactions
- Barrier Structure and Function Studies
- Clostridium difficile and Clostridium perfringens research
- Digestive system and related health
- Escherichia coli research studies
- Gut microbiota and health
- Helicobacter pylori-related gastroenterology studies
- vaccines and immunoinformatics approaches
Identifiers and source
- Literature Corpus work
- c3ec5282-6a39-5aa8-b46c-20487baf8ebd
- DOI
- 10.64898/2026.06.22.733822
